Semaglutide
It is a new long-term glucagon like peptide-1 (GLP-1) analog of Novo Nordisk, which is used to control the blood sugar of adult type 2 diabetes patients who receive metformin and/or sulfonylurea drugs and whose blood sugar is not up to the standard on the basis of diet control and exercise, And reduce the risk of major cardiovascular adverse events (cardiovascular death, nonfatal myocardial infarction or nonfatal stroke) in adult patients with type 2 diabetes accompanied by cardiovascular disease.
CAS No.: 910463-68-2
分子式:C187H291N45O59
分子量:4113.64
序列:His-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-N6-[N-(17-carboxy-1-oxoheptadecyl-L-γ-glutamyl[2-(2-aminoethoxy)ethoxy] acetyl[2-(2-aminoethoxy)
ethoxy]acetyl]-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH